Sanofi-Aventisand Regeneron Pharmaceuticals said Monday that their investigational cancer drug Zaltrap led to longer survival of patients with metastatic colorectal cancer compared to an older treatment.The companies, which tested 1,226 patients with colorectal cancer that had been previously treated with oxaliplatin or bevacizumab, said Zaltrap “significantly improved” both overall survival and progression-free survival.“We are excited by these results and are committed to bringing this novel therapy to patients as soon as possible,” Dr. Debasish Roychowdhury, senior vice president and of Sanofi Oncology said in a statement.The pharmaceutical giants plan on submitting regulatory applications for marketing approval of Zaltrap to the U.S. Food and Drug Administration and the European Medicines Agency in the second half of this year.The latest development is part of a collaboration between Sanofi Oncology and Regeneron in combining Zaltrap with common chemotherapy regimens to treat patients with advanced cancers.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac... -
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma... -
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th... -
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y... -
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after... -
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ... -
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment